Philippe M
Director
Board of directors
Widewaters
Spain
Biography
Philippe Monteyne MD, PhD is a partner at Fund+ in Belgium. He has also been a visiting professor of neurosciences at UCL, Catholic University of Louvain in Belgium and vice president of R&D at Sanofi France. Prior to that, Philippe was senior vice president, head of development, and CMO at GSK Rare Diseases. Between 1998 and 2010, he held various executive positions at GlaxoSmithKline Biologicals, the vaccine division of GSK, including head of global vaccine development. Dr Monteyne’s extensive knowledge of the life sciences market will help Aelix with the development of its lead candidate, the HTI immunogen.
Research Interest
Neurology
